Global Psoriatic Arthritis Drug Market Size, Status and Forecast 2020-2026

  • receipt Report ID : 28334
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 90
  • list Pharmaceuticals and Healthcare

In 2020, the global Psoriatic Arthritis Drug market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2020-2026.

This report focuses on the global Psoriatic Arthritis Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Psoriatic Arthritis Drug development in United States, Europe and China.

The key players covered in this study

Abbvie

Janssen

Amgen

Pfizer

Eli-lilly

Celgene

...

Market segment by Type, the product can be split into

TNF Inhibitors

PDE4 Inhibitors

Interleukin Blockers

Other

Market segment by Application, split into

Mild Psoriatic Arthritis

Moderate Psoriatic Arthritis

Severe Psoriatic Arthritis

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Psoriatic Arthritis Drug status, future forecast, growth opportunity, key market and key players.

To present the Psoriatic Arthritis Drug development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Psoriatic Arthritis Drug are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Psoriatic Arthritis Drug Market Size Growth Rate by Type (2015-2026)

1.4.2 TNF Inhibitors

1.4.3 PDE4 Inhibitors

1.4.4 Interleukin Blockers

1.4.5 Other

1.5 Market by Application

1.5.1 Global Psoriatic Arthritis Drug Market Share by Application (2015-2026)

1.5.2 Mild Psoriatic Arthritis

1.5.3 Moderate Psoriatic Arthritis

1.5.4 Severe Psoriatic Arthritis

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Psoriatic Arthritis Drug Market Size

2.2 Psoriatic Arthritis Drug Growth Trends by Regions

2.2.1 Psoriatic Arthritis Drug Market Size by Regions (2015-2026)

2.2.2 Psoriatic Arthritis Drug Market Share by Regions (2015-2020)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Psoriatic Arthritis Drug Market Size by Manufacturers

3.1.1 Global Psoriatic Arthritis Drug Revenue by Manufacturers (2015-2020)

3.1.2 Global Psoriatic Arthritis Drug Revenue Market Share by Manufacturers (2015-2020)

3.1.3 Global Psoriatic Arthritis Drug Market Concentration Ratio (CR5 and HHI)

3.2 Psoriatic Arthritis Drug Key Players Head office and Area Served

3.3 Key Players Psoriatic Arthritis Drug Product/Solution/Service

3.4 Date of Enter into Psoriatic Arthritis Drug Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Psoriatic Arthritis Drug Market Size by Type (2015-2020)

4.2 Global Psoriatic Arthritis Drug Market Size by Application (2015-2020)

5 United States

5.1 United States Psoriatic Arthritis Drug Market Size (2015-2020)

5.2 Psoriatic Arthritis Drug Key Players in United States

5.3 United States Psoriatic Arthritis Drug Market Size by Type

5.4 United States Psoriatic Arthritis Drug Market Size by Application

6 Europe

6.1 Europe Psoriatic Arthritis Drug Market Size (2015-2020)

6.2 Psoriatic Arthritis Drug Key Players in Europe

6.3 Europe Psoriatic Arthritis Drug Market Size by Type

6.4 Europe Psoriatic Arthritis Drug Market Size by Application

7 China

7.1 China Psoriatic Arthritis Drug Market Size (2015-2020)

7.2 Psoriatic Arthritis Drug Key Players in China

7.3 China Psoriatic Arthritis Drug Market Size by Type

7.4 China Psoriatic Arthritis Drug Market Size by Application

8 Japan

8.1 Japan Psoriatic Arthritis Drug Market Size (2015-2020)

8.2 Psoriatic Arthritis Drug Key Players in Japan

8.3 Japan Psoriatic Arthritis Drug Market Size by Type

8.4 Japan Psoriatic Arthritis Drug Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Psoriatic Arthritis Drug Market Size (2015-2020)

9.2 Psoriatic Arthritis Drug Key Players in Southeast Asia

9.3 Southeast Asia Psoriatic Arthritis Drug Market Size by Type

9.4 Southeast Asia Psoriatic Arthritis Drug Market Size by Application

10 India

10.1 India Psoriatic Arthritis Drug Market Size (2015-2020)

10.2 Psoriatic Arthritis Drug Key Players in India

10.3 India Psoriatic Arthritis Drug Market Size by Type

10.4 India Psoriatic Arthritis Drug Market Size by Application

11 Central & South America

11.1 Central & South America Psoriatic Arthritis Drug Market Size (2015-2020)

11.2 Psoriatic Arthritis Drug Key Players in Central & South America

11.3 Central & South America Psoriatic Arthritis Drug Market Size by Type

11.4 Central & South America Psoriatic Arthritis Drug Market Size by Application

12 International Players Profiles

12.1 Abbvie

12.1.1 Abbvie Company Details

12.1.2 Company Description and Business Overview

12.1.3 Psoriatic Arthritis Drug Introduction

12.1.4 Abbvie Revenue in Psoriatic Arthritis Drug Business (2015-2020)

12.1.5 Abbvie Recent Development

12.2 Janssen

12.2.1 Janssen Company Details

12.2.2 Company Description and Business Overview

12.2.3 Psoriatic Arthritis Drug Introduction

12.2.4 Janssen Revenue in Psoriatic Arthritis Drug Business (2015-2020)

12.2.5 Janssen Recent Development

12.3 Amgen

12.3.1 Amgen Company Details

12.3.2 Company Description and Business Overview

12.3.3 Psoriatic Arthritis Drug Introduction

12.3.4 Amgen Revenue in Psoriatic Arthritis Drug Business (2015-2020)

12.3.5 Amgen Recent Development

12.4 Pfizer

12.4.1 Pfizer Company Details

12.4.2 Company Description and Business Overview

12.4.3 Psoriatic Arthritis Drug Introduction

12.4.4 Pfizer Revenue in Psoriatic Arthritis Drug Business (2015-2020)

12.4.5 Pfizer Recent Development

12.5 Eli-lilly

12.5.1 Eli-lilly Company Details

12.5.2 Company Description and Business Overview

12.5.3 Psoriatic Arthritis Drug Introduction

12.5.4 Eli-lilly Revenue in Psoriatic Arthritis Drug Business (2015-2020)

12.5.5 Eli-lilly Recent Development

12.6 Celgene

12.6.1 Celgene Company Details

12.6.2 Company Description and Business Overview

12.6.3 Psoriatic Arthritis Drug Introduction

12.6.4 Celgene Revenue in Psoriatic Arthritis Drug Business (2015-2020)

12.6.5 Celgene Recent Development

13 Market Forecast 2020-2026

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2020-2026)

13.10 Market Size Forecast by Application (2020-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Psoriatic Arthritis Drug Key Market Segments

Table Key Players Psoriatic Arthritis Drug Covered

Table Global Psoriatic Arthritis Drug Market Size Growth R